{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T14:11:16Z","timestamp":1764079876113},"reference-count":26,"publisher":"Japanese Society of Internal Medicine","issue":"21","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2023,11,1]]},"DOI":"10.2169\/internalmedicine.1251-22","type":"journal-article","created":{"date-parts":[[2023,3,21]],"date-time":"2023-03-21T22:10:38Z","timestamp":1679436638000},"page":"3187-3194","source":"Crossref","is-referenced-by-count":1,"title":["A Diagnostic and Therapeutic Dilemma Concerning Exostosin 1\/Exostosin 2-associated Lupus-like Membranous Nephropathy with Positive Antinuclear Antibody in an Elderly Man with Various Immune Abnormalities"],"prefix":"10.2169","volume":"62","author":[{"given":"Mika","family":"Kawagoe","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Teikyo University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohei","family":"Odajima","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Teikyo University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichiro","family":"Asakawa","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Teikyo University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michito","family":"Nagura","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Teikyo University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeyuki","family":"Arai","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Teikyo University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"Yamazaki","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Teikyo University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshifuru","family":"Tamura","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Teikyo University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuji","family":"Ohashi","sequence":"additional","affiliation":[{"name":"Department of Integrated Diagnostic Pathology, Nippon Medical School, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takamasa","family":"Iwakura","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Hamamatsu University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Yasuda","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Hamamatsu University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeru","family":"Shibata","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Teikyo University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihide","family":"Fujigaki","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Teikyo University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Sethi S, Madden BJ, Debiec H, et al. Exostosin 1\/exostosin 2-associated membranous nephropathy. J Am Soc Nephrol 30: 1123-1136, 2019.","DOI":"10.1681\/ASN.2018080852"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Sethi S. Membranous nephropathy: a single disease or a pattern of injury resulting from different diseases. Clin Kidney J 14: 2166-2169, 2021.","DOI":"10.1093\/ckj\/sfab069"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Bobart SA, Tehranian S, Sethi S, et al. A target antigen-based approach to the classification of membranous nephropathy. Mayo Clin Proc 96: 577-591, 2021.","DOI":"10.1016\/j.mayocp.2020.11.028"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Huerta A, Bomback AS, Liakopoulos V, et al. Renal-limited 'lupus-like' nephritis. Nephrol Dial Transplant 27: 2337-2342, 2012.","DOI":"10.1093\/ndt\/gfr663"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Jennette JC, Iskandar SS, Dalldorf FG. Pathologic differentiation between lupus and nonlupus membranous glomerulopathy. Kidney Int 24: 377-385, 1983.","DOI":"10.1038\/ki.1983.170"},{"key":"6","unstructured":"6. Petri M, Orbai AM, Alarc\u00f3n GS, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 64: 2677-2686, 2012."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40: 1725, 1997.","DOI":"10.1002\/art.1780400928"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. In\u00eas L, Silva C, Galindo M, et al. Classification of systemic lupus erythematosus: Systemic Lupus International Collaborating Clinics Versus American College of Rheumatology Criteria. A comparative study of 2,055 patients from a real-life, international systemic lupus erythematosus cohort. Arthritis Care Res (Hoboken) 67: 1180-1185, 2015.","DOI":"10.1002\/acr.22539"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Rijnink EC, Teng YKO, Kraaij T, Dekkers OM, Bruijn JA, Bajema IM. Validation of the Systemic Lupus International Collaborating Clinics classification criteria in a cohort of patients with full house glomerular deposits. Kidney Int 93: 214-220, 2018.","DOI":"10.1016\/j.kint.2017.07.017"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Iwakura T, Ema C, Isobe S, et al. Prevalence of neural epidermal growth factor-like 1- and exostosin 1\/exostosin 2-associated membranous nephropathy: a single-center retrospective study in Japan. Sci Rep 12: 2967, 2022.","DOI":"10.1038\/s41598-022-07037-2"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Fujibayashi T, Sugai S, Miyasaka N, Hayashi Y, Tsubota K. Revised Japanese criteria for Sj\u00f6gren's syndrome (1999): availability and validity. Mod Rheumatol 14: 425-434, 2004.","DOI":"10.1007\/s10165-004-0338-x"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Fran\u00e7ois H, Mariette X. Renal involvement in primary Sj\u00f6gren syndrome. Nat Rev Nephrol 12: 82-93, 2016.","DOI":"10.1038\/nrneph.2015.174"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Yang HX, Wang J, Wen YB, et al. Renal involvement in primary Sj\u00f6gren's syndrome: a retrospective study of 103 biopsy-proven cases from a single center in China. Int J Rheum Dis 21: 223-229, 2018.","DOI":"10.1111\/1756-185X.13182"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Luo J, Xu S, Lv Y, et al. Clinical features and potential relevant factors of renal involvement in primary Sj\u00f6gren's syndrome. Int J Rheum Dis 22: 182-190, 2019.","DOI":"10.1111\/1756-185X.13429"},{"key":"15","first-page":"57","volume":"58","author":"T Doi","year":"1984","unstructured":"15. Doi T, Mayumi M, Kanatsu K, Suehiro F, Hamashima Y. Distribution of IgG subclasses in membranous nephropathy. Clin Exp Immunol 58: 57-62, 1984.","journal-title":"Clinical & Experimental Immunology","ISSN":"http:\/\/id.crossref.org\/issn\/0009-9104","issn-type":"print"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Jarrot PA, Chiche L, Hervier B, et al. Systemic lupus erythematosus and antineutrophil cytoplasmic antibody-associated vasculitis overlap syndrome in patients with biopsy-proven glomerulonephritis. Medicine (Baltimore) 95: e3748, 2016.","DOI":"10.1097\/MD.0000000000003748"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Ali YM, Urowitz MB, Ibanez D, Gladman DD. Monoclonal gammopathy in systemic lupus erythematosus. Lupus 16: 426-429, 2007.","DOI":"10.1177\/0961203307079045"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Bettacchioli E, Le Gaffric C, Mazeas M, et al. An elevated polyclonal free light chain level reflects a strong interferon signature in patients with systemic autoimmune diseases. J Transl Autoimmun 4: 100090, 2021.","DOI":"10.1016\/j.jtauto.2021.100090"},{"key":"19","doi-asserted-by":"publisher","unstructured":"20. Choi JH, Park DJ, Kang JH, et al. Comparison of clinical and serological differences among juvenile-, adult-, and late-onset systemic lupus erythematosus in Korean patients. Lupus 24: 1342-1349, 2015.","DOI":"10.1177\/0961203315591024"},{"key":"20","doi-asserted-by":"crossref","unstructured":"21. Hanset N, Aydin S, Demoulin N, et al. Podocyte antigen staining to identify distinct phenotypes and outcomes in membranous nephropathy: a retrospective multicenter cohort study. Am J Kidney Dis 76: 624-635, 2020.","DOI":"10.1053\/j.ajkd.2020.04.013"},{"key":"21","doi-asserted-by":"crossref","unstructured":"22. Ravindran A, Casal Moura M, Fervenza FC, et al. In patients with membranous lupus nephritis, exostosin-positivity and exostosin-negativity represent two different phenotypes. J Am Soc Nephrol 32: 695-706, 2021.","DOI":"10.1681\/ASN.2020081181"},{"key":"22","doi-asserted-by":"crossref","unstructured":"23. Wang C, Liu Y, Zhang M, et al. Glomerular exostosin as a subtype and activity marker of class 5 lupus nephritis. Clin J Am Soc Nephrol 17: 986-993, 2022.","DOI":"10.2215\/CJN.00350122"},{"key":"23","doi-asserted-by":"crossref","unstructured":"24. Sa\u00efdi M, Broch\u00e9riou I, Est\u00e8ve E, et al. The exostosin immunohistochemical status differentiates lupus membranous nephropathy subsets with different outcomes. Kidney Int Rep 6: 1977-1980, 2021.","DOI":"10.1016\/j.ekir.2021.04.025"},{"key":"24","doi-asserted-by":"crossref","unstructured":"25. Miller PP, Caza T, Larsen CP, Charu V. EXT1 and NCAM1-associated membranous lupus nephritis in a cohort of patients undergoing repeat kidney biopsies. Nephrol Dial Transplant 12: 396-404, 2023.","DOI":"10.1093\/ndt\/gfac058"},{"key":"25","doi-asserted-by":"crossref","unstructured":"26. Wada Y, Iyoda M, Suzuki T, et al. Immunopathological analysis of the expression of glomerular exostosin 1 and exostosin 2 in Japanese patients with lupus nephritis. Virchows Arch 479: 997-1005, 2021.","DOI":"10.1007\/s00428-021-03164-9"},{"key":"26","doi-asserted-by":"crossref","unstructured":"27. Chen R, Wang J, Xie Q, Xue J, Hao C. Sj\u00f6gren's syndrome complicated with membranous nephropathy, a cause or coincidence? Int J Rheum Dis 24: 1086-1094, 2021.","DOI":"10.1111\/1756-185X.14168"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/21\/62_1251-22\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T03:24:19Z","timestamp":1699068259000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/21\/62_1251-22\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,1]]},"references-count":26,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.1251-22","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,1]]},"article-number":"1251-22"}}